Yuriko Minami
Angel Investor @ MIRAI SOUZOU
Yuriko Minami is a Series A investor at MIRAI SOUZOU focused on Medical and Biotechnology. Yuriko Minami is the Capitalist at Mirai Sozo Organization.
- Total investments:
- 6
- Last investment:
- Lead investor:
- 17%
Last updated:
For AI agents: llms.txt
Industries Yuriko Minami invests in
Stages Yuriko Minami invests in
Countries Yuriko Minami invests in
Round sizes
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Round size
- Series A
- $3M–$4.7M
Investment Focus
Industry
- Medical 2 (33%)
- Biotechnology 2 (33%)
- SNS 1 (17%)
- Apps 1 (17%)
- Content 1 (17%)
Stage
- Series A 2 (33%)
- Seed 1 (17%)
- Pre-Seed 1 (17%)
- Series B 1 (17%)
- Series D 1 (17%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Varinos is a clinical laboratory contract analysis company that is a partner of medical institutions. Varinos provides genomic testing development and contract analysis services using the latest technology, the next-generation sequencer. | $7.9M / Series D / May 12, 2026 | ||
| Metagen Therapeutics (MGTx) is a clinical-stage company operating Japan’s first GMP-compliant manufacturing platform for fecal microbiota transplantation (FMT) therapies. The company combines proprietary paired metagenomic datasets with AI/ML-driven donor-recipient matching to advance precision microbiome medicine across ulcerative colitis,immuno-oncology, and neurodegenerative disease. Headquartered in Tsuruoka, Japan, MGTx leverages a cross-border regulatory strategy spanning PMDA and FDA pathways, positioning it as a platform bridging Japanese clinical innovation with global market access. | $15.7M / Series B / Sep 08, 2025 | ||
| ARCS specializes in developing assisted reproductive medical devices using robotics and artificial intelligence technology. | $3.4M / Seed / Jan 20, 2025 | ||
| Digzyme develops new enzymatic processes using bioinformatics. The company automates various stages of analysis related to the development of enzymes and bioprocesses using their core bioinformatics technology and further optimize using accumulated data. | $4.7M / Series A / Apr 23, 2024 | ||
| A10 Lab is a company that aims to make people happy with technology that is independent of Sony's new business creation program. It provides Google Play with an app that allows users to do things that they have never been able to do with the custom app 'Min Chale' selected for two consecutive years. It is a company that bringsprofits to companies by improving lifetime value sales through the habitation of users that companies have. | $3M / Series A / Jan 22, 2024 | ||
| ARCS specializes in developing assisted reproductive medical devices using robotics and artificial intelligence technology. | $522K / Pre-Seed / Apr 24, 2023 |
Co-Investors
About MIRAI SOUZOU
MIRAI SOUZOU operates as a venture capital firm that invests in institutional lookup and supporting projects. The Company invests in institutional research and development supporting projects, medicine, agriculture, ocean field, and other industries. Innovations and Future Creation conducts businesses in Japan.
MIRAI SOUZOU Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Daisuke Kaneko
Co-Founder & Director
|
|||
Yumiko Nagatsuma
Partner
|
|||
|
Yuyuki Okada
President and CEO
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Yuriko Minami invest in?
Yuriko Minami invests primarily in Medical, Biotechnology and SNS startups, most often at Series A and Seed stage. Most of the 6 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Yuriko Minami invest in?
Yuriko Minami typically joins rounds of $3M–$4.7M at Series A. These are whole funding-round sizes, not Yuriko Minami's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Yuriko Minami took part in.
How do I contact Yuriko Minami?
For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Yuriko Minami last invest?
The most recent investment recorded for Yuriko Minami closed in May 2026. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
